Wave Life Sciences Ltd. (WVE)
$3.46-0.29%Close
SELLCRISIS · day 35
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $666M
- Beta
- -1.43
- P/E (TTM)
- -3.23
- Short % float
- 11.71%
- Days to cover
- 5.7
- SI change
- +5.2%
- 1W
- -8.47%
- 1M
- -25.91%
- vs SPY 1W
- -9.63%
- vs SPY 1M
- -28.90%
Industry peers
FMP comparable companies · ranked by market cap
- SYRESELLSpyre Therapeutics, Inc.$8.1BCRISISQ 10$92.72+7.25%
- TERNTerns Pharmaceuticals, Inc.$4.8B$52.95
- ELVNSELLEnliven Therapeutics, Inc.$3.2BCRISISQ 11$45.47+0.86%
- AMLXSELLAmylyx Pharmaceuticals, Inc.$3.1BCRISISQ 8$27.78+3.46%
- PGENBUYPrecigen, Inc.$2.8BBULLQ 10$7.74+2.76%
- NTLABUYIntellia Therapeutics, Inc.$1.8BRECOVERYQ 4$12.75+3.73%
- ZBIOSELLZenas BioPharma, Inc.$1.8BCRISISQ 15$27.83+3.89%
- ORICSELLORIC Pharmaceuticals, Inc.$1.3BBEARQ 3$12.49-0.33%
- TRMLTourmaline Bio, Inc.$1.2B$47.98
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on WVE?
- LOPJLB’s latest quantitative signal on Wave Life Sciences Ltd. (WVE) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is WVE in?
- Wave Life Sciences Ltd. (WVE) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Wave Life Sciences Ltd. (WVE) do?
- Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The companyâs medicines platform, PRISM combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent …